All episodes
Comparative Accuracy of TCD, TTE, TEE, and Cardiac CT for Detecting Right-to-Left Shunt in ESUS
Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome
Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome
Understanding Rett Syndrome - Part 4
Lab Minute: MTHFR
June 2026 President Spotlight: Community at the AAN
New Resident Guide to Stroke Alerts - Part 2
New Resident Guide to Stroke Alerts - Part 1
Understanding Rett Syndrome - Part 3
Shunting for Idiopathic Normal Pressure Hydrocephalus
Recent Updates in Central Retinal Artery Occlusions
Prion Disease Clinical Trial NN112
Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 2
Understanding Rett Syndrome - Part 2
Lower Risk of Dementia with AS01-Adjuvanted Vaccination Against Shingles and Respiratory Syncytial Virus Infections
Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 3
Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 1
Inflammation, Limbic White Matter, and Symptoms After Repetitive Head Impacts in Retired Football Players
Understanding Rett Syndrome - Part 1
Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 2
Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 1
Updates Regarding Radiation Necrosis - Part 1
Association of Changes in Activity Patterns With Brain Atrophy and Disability Progression in People With MS
Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease - Part 2
Workplace Lactation in Neurology: Barriers and Opportunities - Part 2
May 2026 President Spotlight: AAN Annual Meeting Update
Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease - Part 1
Workplace Lactation in Neurology: Barriers and Opportunities - Part 1
Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 3
Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 2
Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases - Part 2
Clinical Reasoning Series: A 70-Year-Old Man With Systemic Illness Related Strokes Refractory to Medical Treatment Managed With Intracranial Stent
Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases - Part 1
Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1
April 20, 2026 Capitol Hill Report: Neuroscience Research in FY2027
Navigating the Residency Application Process: Key Takeaways for Aspiring Neurologists
Trends in Head CT Use in US Emergency Department Patients
A Discussion with Dr. Alison Christy: 2026 Ted Burns Humanism in Neurology Award Winner
Global Burden of Headache Disorders in Older Adults (Aged ≥ 55 Years) from 1990-2021
Diagnostic Utility and Prognostic Significance of Circulating Tumor Cell Assay CNSide in Patients With Suspicion for Leptomeningeal Metastases - Part 3
Diagnostic Utility and Prognostic Significance of Circulating Tumor Cell Assay CNSide in Patients With Suspicion for Leptomeningeal Metastases - Part 2
2026 AAN President's Award Recipient - Dr. Walter J. Koroshetz
A Path to Preventing Cognitive Impairment Due to Alzheimer's Disease
Diagnostic Utility and Prognostic Significance of Circulating Tumor Cell Assay CNSide in Patients With Suspicion for Leptomeningeal Metastases - Part 1
TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2
April 6, 2026 Capitol Hill Report: Proposed Budget Cuts, New Bills
History of Letters to the Editor
Landmark Clinical Trials Shaping Patient Care
TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 1
FDA Revises Trial Requirements for Drug and Medical Product Approval - Part 2
April 2026 President Spotlight: Supporting Neurology in Every Practice Setting
Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD
FDA Revises Trial Requirements for Drug and Medical Product Approval - Part 1
Real-World Implementation of an AI Clinical Assistant in Neurology
A Roadmap to Neurological Health Equity - Part 2
A Roadmap to Neurological Health Equity - Part 1
Periprocedural Brain Health
Neurological Sequelae After Ebola Virus Disease in Children in Liberia
Lab Minute: Micronutrient Screening
Lab Minute: Chronic Wasting Disease
Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 2
Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia
Migraine Clinical Trials from 2025
Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 1
Refractory Headache Disorders, New Consensus, and Emergency Department Migraine Guidelines - Part 2
March 9, 2026 Capitol Hill Report: Our 2026 Advocacy Priorities
Seizures and Epilepsy in Patients With Untreated Cerebral Cavernous Malformations
Refractory Headache Disorders, New Consensus, and Emergency Department Migraine Guidelines - Part 1
Lab Minute: Vitamin B7
February 23, 2026 Capitol Hill Report: Neurology on the Hill
March 2026 President Spotlight: Preview of the Annual Meeting
The Best of Headache Medicine from 2025: A Year in Review
Overview from the 2026 International Stroke Conference - Part 2
Overview from the 2026 International Stroke Conference - Part 1
How Non-Traditional Educational Formats are Reshaping Neurology Training - Part 4
Consensus Recommendations for Diagnosis and Management of Vanishing White Matter - Part 2
2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke
Consensus Recommendations for Diagnosis and Management of Vanishing White Matter - Part 1
Neurology on the Hill 2026 - Part 3
Neurology on the Hill 2026 - Part 2
Neurology on the Hill 2026 - Part 1
Clinical Insights Into CASPR1 and CASPR1/Contactin-1 Complex Autoimmune Nodopathies
Diagnostic Yield of Reanalysis After Nondiagnostic Genome Sequencing in Infants With Unexplained Epilepsy
How Non-Traditional Educational Formats are Reshaping Neurology Training - Part 3
How Non-Traditional Educational Formats are Reshaping Neurology Training - Part 2
Fremanezumab in Children and Adolescents with Episodic Migraine - Part 2
CSF α-Synuclein Seed Amplification Assays and Alzheimer's Disease Biomarkers
Fremanezumab in Children and Adolescents with Episodic Migraine - Part 1
February 9, 2026 Capitol Hill Report: State Advocacy Update
February 2026 President Spotlight: Expanding the AAN's Fundraising for Research Grants
Understanding Physical Exam Findings Associated With FND - Part 4
How Non-Traditional Educational Formats are Reshaping Neurology Training - Part 1
Physician as Patient Series - Stroke and Cancer Survivor
Rethinking How We Evaluate Small Fiber Neuropathy
Understanding Physical Exam Findings Associated With FND - Part 3
US Burden of Disorders Affecting the Nervous System - Part 2
CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke
US Burden of Disorders Affecting the Nervous System - Part 1
Understanding Physical Exam Findings Associated With FND - Part 2
Understanding Physical Exam Findings Associated With FND - Part 1